Remove 2022 Remove Competition Remove Pharma
article thumbnail

The perfect storm is coming for pharma

World of DTC Marketing

The true risk to pharma in response to unacceptable drug pricing may come from growing bipartisan support to increase industry antitrust scrutiny and penalties. Eight US antitrust bills targeting the pharmaceutical industry have been recently introduced, addressing a gamut of alleged anti-competitive activity. AARP Drug Pricing.

Pharma 187
article thumbnail

Global pharma confidence highest on record, shows CPhI Pharma Index

European Pharmaceutical Review

Results from CPhI’s 2022 Pharma Index survey , announced at this year’s CPhI Frankfurt, showed pharma confidence in growth , innovation and manufacturing quality has reached record highs, promising positive prospects for the industry in 2023 and beyond. Competitiveness. Key countries. Finished Dosage. Growth potential.

Pharma 103
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Azico Biophore India Pvt. Ltd- Walk-In Interview for Production & Documentation On 17th Dec’ 2022

Pharma Pathway

Ltd- Walk-In Interview for Production & Documentation On 17th Dec’ 2022. Azico is one of the few independent Indian API manufacturing with world class infrastructure, having at single location, 7 Pharma blocks with dedicated clean room of class 100, 000 with HEPA filters. Date : 17th Dec’ 2022. Job Description.

article thumbnail

Financial factors to support and challenge Pharma in 2024

European Pharmaceutical Review

Data outcomes revealed that most respondents from Pharma considered that drug pricing and reimbursement constraints will have a negative impact in 2024. The report recommened that to gain a competitive edge in the market, focusing on modernising R&D models or implementing emerging technologies could support this endeavour.

Pharma 102
article thumbnail

Collaborations between pharma and academia increase

European Pharmaceutical Review

The benefits of exposing students to the industry this way enables both parties to share knowledge, experience and provides students networking opportunities that can be difficult to obtain for such a competitive industry, said ABPI. It also found that The University of Bath, UK hosted the most industry placements: 61 in 2019 and 2022.

Pharma 104
article thumbnail

FDA approves long-acting injectable for schizophrenia and bipolar disorder

European Pharmaceutical Review

According to 2022 data gathered by the World Health Organization (WHO), there are around 24 million schizophrenia patients. “Rykindo ® is our first new drug developed in-house and approved for marketing in the US,” declared Yang Rongbing, President of Luye Pharma Group. Promising schizophrenia drug faces tough competition.

article thumbnail

Emcure Pharmaceuticals-Walk-In Interviews for Quality Assurance (Injectable) On 25th Sept’ 2022

Pharma Pathway

Emcure Pharmaceuticals-Walk-In Interviews for Quality Assurance (Injectable) On 25th Sept’ 2022. Emcure’s differentiated product portfolio lends and unparalleled competitive advantage establishing its presence in all major therapies in the domestic market. Date of Interview: 25th Sept’ 2022. Job Description.